These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7610990)

  • 21. Cyclooxygenase-2 inhibitors: a new approach to the therapy of ocular inflammation.
    Masferrer JL; Kulkarni PS
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S35-40. PubMed ID: 9154274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract.
    Meyer-Kirchrath J; Schrör K
    Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase.
    Seibert K; Masferrer J; Zhang Y; Leahy K; Hauser S; Gierse J; Koboldt C; Anderson G; Bremer M; Gregory S
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():125-7. PubMed ID: 7794421
    [No Abstract]   [Full Text] [Related]  

  • 24. From prostaglandin replacement to specific COX-2 inhibition: a critical appraisal.
    Kremer J
    J Rheumatol Suppl; 2000 Oct; 60():9-12. PubMed ID: 11032096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
    Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
    Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
    Buskens CJ; Ristimäki A; Offerhaus GJ; Richel DJ; van Lanschot JJ
    Scand J Gastroenterol Suppl; 2003; (239):87-93. PubMed ID: 14743889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meloxicam: selective COX-2 inhibition in clinical practice.
    Furst DE
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):21-7. PubMed ID: 9219316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.
    Everts B; Währborg P; Hedner T
    Clin Rheumatol; 2000; 19(5):331-43. PubMed ID: 11055820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of cyclooxygenase-1 and -2 in the rat formalin test.
    Yamamoto T; Nozaki-Taguchi N
    Anesth Analg; 2002 Apr; 94(4):962-7, table of contents. PubMed ID: 11916805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
    Radi ZA; Khan NK
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [NSAIDs caused gastric mucosal injury: with a special reference to COX-2].
    Sakamoto C
    J Nippon Med Sch; 2003 Feb; 70(1):5-11. PubMed ID: 12646969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract.
    Masferrer JL; Isakson PC; Seibert K
    Gastroenterol Clin North Am; 1996 Jun; 25(2):363-72. PubMed ID: 9229578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of COX-2-selective inhibitors.
    Brater DC; Harris C; Redfern JS; Gertz BJ
    Am J Nephrol; 2001; 21(1):1-15. PubMed ID: 11275626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cyclooxygenase (COX)-2 selective inhibitors: aspirin, a dual COX-1/COX-2 inhibitor, to COX-2 selective inhibitors].
    Nakamura H
    Nihon Yakurigaku Zasshi; 2001 Sep; 118(3):219-30. PubMed ID: 11577463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.
    Kulkarni SK; Jain NK; Singh A
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):291-8. PubMed ID: 11031730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes.
    Mazario J; Gaitan G; Herrero JF
    Neuropharmacology; 2001 Jun; 40(7):937-46. PubMed ID: 11378164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of aspirin-like drugs.
    Vane JR; Botting RM
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory drugs and their mechanism of action.
    Vane JR; Botting RM
    Inflamm Res; 1998 Oct; 47 Suppl 2():S78-87. PubMed ID: 9831328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new NSAIDs: cox-2 inhibitors.
    Capriotti T
    Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclo-oxygenase isoenzymes: physiological and pharmacological role.
    Kam PC; See AU
    Anaesthesia; 2000 May; 55(5):442-9. PubMed ID: 10792135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.